Request Deal Involvement
The gene therapy unit of Amicus Therapeutics to go public via merger with ARYA Sciences Acquisition IV in a $600m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Wilson Sonsini Goodrich & Rosati
legal advisors
Troutman Pepper
legal advisors
Skadden Arps Slate Meagher & Flom
financial advisors
Goldman Sachs
legal advisors
Kirkland & Ellis
financial advisors
Jefferies & Company
or
Principals
vendor
AMICUS THERAPEUTICS
bidder
ARYA SCIENCES ACQUISITION CORP IV
target
AMICUS THERAPEUTICS (GENE THERAPY BUSINESS)
bidder
PERCEPTIVE ADVISORS LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite